Keywords: Deuterium, Cancer
Aberrant choline phospholipid biosynthesis is a metabolic hallmark of cancer. Choline kinase α (CKα) is the key enzyme in this pathway. Non-invasive methods of imaging CKα have the potential to report on tumor proliferation. Here, using a combination of RNA interference and doxycycline-inducible gene silencing systems, we show that deuterium magnetic resonance spectroscopy following administration of [2H9]-choline non-invasively reports on CKα activity in patient-derived glioma cells and intracranial tumors. Importantly, [2H9]-choline provides an early readout of response to chemotherapy in mice bearing intracranial gliomas. Our studies identify a novel agent for metabolic imaging of gliomas and their response to therapy.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords